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The value of cerebrospinal fluid (CSF) lactate level and CSF/blood glucose ratio for the identifi-
cation of bacterial meningitis following neurosurgery was assessed in a retrospective study. During
a 3-year period, 73 patients fulfilled the inclusion criteria and could be grouped by preset criteria in
one of three categories: proven bacterial meningitis (n 5 12), presumed bacterial meningitis (n 5 14),
and nonbacterial meningeal syndrome (n 5 47). Of 73 patients analyzed, 45% were treated with
antibiotics and 33% with steroids at the time of first lumbar puncture. CSF lactate values (cutoff, 4
mmol/L), in comparison with CSF/blood glucose ratios (cutoff, 0.4), were associated with higher
sensitivity (0.88 vs. 0.77), specificity (0.98 vs. 0.87), and positive (0.96 vs. 0.77) and negative (0.94 vs.
0.87) predictive values. In conclusion, determination of the CSF lactate value is a quick, sensitive,
and specific test to identify patients with bacterial meningitis after neurosurgery.
The diagnosis of bacterial meningitis (BM) is difficult in
patients after neurosurgery for several reasons. Meningeal syn-
drome with stiff neck, fever, and headache occurs frequently in
patients following craniotomy [1–3]. Up to 50% of patients
with clinical signs of meningitis have already been treated with
steroids or antibiotics, at the time of lumbar puncture [4, 5].
Standard CSF studies (i.e., gram staining and determinations of
leukocyte count and glucose and protein concentration) are
unreliable for the diagnosis of BM after neurosurgery [4].
Therefore, additional CSF parameters that allow differentiation
of BM from nonbacterial meningeal syndrome (NBMS) are
needed.
CSF lactate levels and CSF/blood glucose ratios have re-
ceived increasing attention because of the ease and precision
with which they are measured in the clinical laboratory. Al-
though the CSF lactate level and, to a lesser degree, the
CSF/blood glucose ratio do differentiate BM from aseptic
meningitis in spontaneously occurring cases, there is an ongo-
ing controversy about the usefulness of determining these
values rather than performing standard CSF studies [6–15].
CSF lactate in BM originates from different sources. Bacte-
rial pathogens themselves produce varying amounts of lactate,
accounting for ;10% of total CSF lactate in patients with BM
[6]. The main source of lactate in BM is brain tissue, including
neurons and glia cells, which produce lactate by distinct mech-
anisms [16]. First BM is associated with generalized brain
edema, causing a reduction of global cerebral blood flow and
inflammatory involvement of the vasculature, with loss of
autoregulatory mechanisms, vasospasms, and thrombosis [17–
19]. This leads to cerebral ischemia and consequently to gly-
colysis by means of anaerobic metabolism.
In addition, cytokines that flood the brain in meningitis
reduce tissue oxygen uptake and cause a shift toward anaerobic
metabolism, thus increasing lactate production [16, 20]. Be-
cause lactate penetrates the blood-brain barrier at a very low
rate, measurement of CSF lactate is a useful index of cerebral
metabolism [7]. In addition, cytokines also mediate invasion of
neutrophils into the subarachnoid space, which may also con-
tribute to the rise in CSF lactate level by glycolysis [21].
Standard CSF tests for the diagnosis of BM in neurosurgical
patients have been evaluated in only one retrospective study
[4]. The authors found that the examined parameters (total and
differential leukocyte counts, gram stains, and values for glu-
cose and total protein) are either not sensitive or not specific
enough to reliably distinguish BM from NBMS. In spontane-
ously occurring meningitis, CSF lactate level has proved to be
a more reliable discriminatory factor than the CSF/blood glu-
cose ratio [6, 9–11, 22, 23]. The present study was performed
to evaluate the value of CSF lactate level and CSF/blood
glucose ratio for the diagnosis of BM in patients with clinically
suspected BM following neurosurgery.
Patients and Methods
Data from all consecutive lumbar punctures performed over
a 3-year period, from 1 December 1993 to 1 December 1996,
in the neurosurgical ward and the surgical intensive care unit at
the University Hospitals of Basel, Switzerland, were collected
by review of the logbook from the CSF analysis laboratory.
Data were screened by review of the patients’ charts for eligi-
bility. Inclusion criteria were as follows: (1) the first lumbar
puncture per patient was performed within 40 days after neu-
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rosurgery; (2) there was complete documentation of bacterial
gram staining and culture results and of the total and differen-
tial leukocyte count, CSF/blood glucose ratio, and CSF lactate
level; and (3) lumbar puncture was performed when BM was
clinically suspected. Patients with sepsis syndrome due to
causes other than BM were excluded from the analysis.
Patients with clinically suspected BM were categorized ac-
cording to the following preset criteria: (1) for proven BM, a
positive bacterial CSF culture and a leukocyte count of
.250/mL; (2) for presumed BM, .1,000 WBCs/mL with
.50% neutrophils or (if the patient was treated with steroids
and/or antibiotics at the time of the first lumbar puncture) .250
WBCs/mL with .50% neutrophils; and (3) for non-BM, a
negative CSF culture and ,250 WBCs/mL with ,50% neu-
trophils. Criteria for the clinical categories were established
prior to the evaluation.
Clinical parameters examined were age, sex, type of surgery,
presence and type of a foreign device, postoperative day on
which lumbar puncture was performed, amount of blood in the
CSF sample, the antibiotic and/or steroid regimen initiated
before and at the time of lumbar puncture, and organism(s)
identified by CSF culture.
All patients received as antibiotic prophylaxis either fusidic
acid (500 mg iv for craniotomy) or cefamandole (2 g iv for
spinal cord surgery), as a single dose at induction of anesthesia.
CSF culture and laboratory analysis of CSF and blood were
performed within 2 hours of lumbar puncture by the central
laboratory for bacteriology and chemistry. Leukocytes, neutro-
phils, and erythrocytes were assessed by cell counting, and
lactate and glucose were measured with use of a commercially
available test (Dimension; DuPont, Wilmington, DE) accord-
ing to the manufacturer’s instructions.
Published guidelines for differentiation between spontane-
ously occurring BM and nonbacterial meningitis involve the
use of discriminatory limits with ranges of 3.5–4.2 mmol/L for
CSF lactate and 0.4–0.5 for CSF/blood glucose ratio [6–15].
In this study we chose a cutoff of 4 mmol/L for the CSF lactate
level and 0.4 for the CSF/blood glucose ratio. These were
chosen to maximize discrimination between proven or pre-
sumed BM and NBMS and to be simple enough to be remem-
bered in clinical practice.
Continuous data were compared by the Student’s t test. The
association between continuous variables was assessed by the
Pearson correlation coefficient. Fisher’s exact test was used to
evaluate categorical data. Sensitivity, specificity, and predic-
tive values were calculated by standard formulas.
Results
Over the 3-year period, 477 consecutive lumbar punctures
were performed, because of a clinical suspicion of BM, in the
neurosurgical ward and the surgical intensive care unit. For 164
samples, the results of bacterial gram staining and culture as
well as the total and differential leukocyte counts, CSF/blood
glucose ratio, and CSF lactate level were documented. After
screening of these 164 samples by review of the patients’
charts, the findings of 77 first diagnostic lumbar punctures
performed after neurosurgery were analyzed.
We excluded 75 other lumbar punctures because they were
performed as follow-up punctures, 9 others because of the lack
of a neurosurgical intervention, 1 other because the patient had
a concurrent sepsis syndrome other than BM, and 2 others
because of insufficient clinical documentation. Eighteen pa-
tients had a positive bacterial CSF culture. All positive culture
results were reviewed for relevance with regard to the patient’s
clinical course, treatment received, subsequent culture results,
and laboratory data; this review was done by an investigator
(W.Z.) who was unaware of the CSF lactate level and
CSF/blood glucose ratio at first lumbar puncture.
Propionibacterium acnes in CSF culture was considered
relevant in two patients with foreign devices. Six patients were
categorized as having NBMS despite the positivity of the CSF
culture, which was considered to be due to contamination. In
all six patients’ cultures, bacterial growth was detected only
after .5 days, and the cultures of subsequent CSF samples
remained negative despite the fact that no antibiotic therapy
was initiated. Microorganisms identified in these 6 CSF sam-
ples were P. acnes (n 5 3), coagulase-negative staphylococci
(n 5 2), and mixed isolates of Enterobacter cloacae and
Citrobacter diversus (n 5 1).
The prevalence of BM was high (34%), since only patients
with clinically suspected BM were included. Twelve patients
with microbiologically proven BM (table 1), 14 with presumed
BM, and 47 patients with NBMS were analyzed. Four patients
did not fulfill the criteria for inclusion in any of the above
groups. No statistically significant differences between groups
were found for age, sex, or contamination of CSF samples with
blood.
In this study, 33 patients (45%) received antibiotics and 24
(33%) received steroids at the time of the first lumbar puncture.
The rate of treatment in the combined (presumed or proven)
BM group vs. that in the NBMS group was significantly higher
(P , .002) with steroids (58% [15 of 26] vs. 19% [9 of 47]) but
not with antibiotics (46% [12 of 26] vs. 45% [21 of 47]). In 25
patients (34%) an intraventricular shunt was present at the time
of lumbar puncture, but there was no significant association
with a specific group.
CSF lactate values were significantly higher for patients with
proven BM than for patients with NBMS (mean 6 SD, 7.8 6
3.6 mmol/L vs. 2.3 6 0.8 mmol/L; P , .0001), but they did not
differ markedly from those for patients with presumed BM
(6.7 6 3.3; P 5 NS vs. proven BM and P , .0001 vs. NBMS)
(figure 1). The CSF/blood glucose ratio was significantly lower
in patients with proven BM (median [range], 0.17 [0–1]) and
presumed BM (0.34 [0.1–0.9]) than for patients with NBMS
(0.54 [0.9–0.2]; P , .0001 vs. proven BM and P , .0005 vs.
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presumed BM) (figure 2). For the differentiation of spontane-
ously occurring BM from aseptic meningitis, discriminatory
levels of CSF lactate and ratios of CSF/blood glucose have
been postulated as 3.5–4.2 mmol/L and ,0.4–0.5, respec-
tively [6, 9–11, 22, 23].
In this study, we chose a CSF lactate concentration of .4.0
mmol/L and a CSF/blood glucose ratio of ,0.4 as the critical
values for the diagnosis of BM. To evaluate the diagnostic
performance of the tests, we combined proven and presumed
BM. As presented in figure 1, CSF lactate concentration at a
cutoff of 4 mmol/L did differentiate proven and presumed BM
from NBMS. There was an overlap in 4 cases, with 3 false-
negatives in the combined BM group and 1 false-positive in the
NBMS group. The CSF lactate cutoff level of .4 mmol/L as a
discriminant factor for BM had a sensitivity of 88%, a speci-
ficity of 98%, a positive predictive value of 96%, and a nega-
tive predictive value of 94% (table 2).
The CSF/blood glucose ratio cutoff of 0.4 discriminated
between patients with culturally proven BM and patients with
NBMS, with two false-negatives in the proven BM group and
six false-positives in the NBMS group (figure 2). However, in
the group with presumed BM, where additional information
would be most desirable, the values showed considerable over-
lap, with four false-negatives (30%). Therefore, determination
of the ratio was not helpful in this group of patients. For the
CSF/blood glucose ratio, in a comparison of the combined BM
group and the NBMS group, sensitivity was 77%, specificity
was 87%, positive predictive value was 77%, and negative
predictive value was 87% (table 2).
To evaluate specificity, we analyzed our data for a possible
effect of CSF contamination with blood on lactate concentra-
tion. CSF lactate levels in samples with .500 erythrocytes/mL
were compared to those in samples with ,500
erythrocytes/mL, in patients with and without BM. In accor-
dance with previous observations, lactate values were not sig-
nificantly affected by the presence of red cells [7, 8]. In
addition, we assessed the correlation between the lactate con-
centration in CSF and the number of neutrophils and leuko-
cytes in CSF. In the NBMS group, the two variables were not
correlated (r 5 .1 and P 5 NS for neutrophils; r 5 . 17 and
P 5 NS for leukocytes). However, in the BM group the
correlation was significant (r 5 .72 and P , .001 for neutro-
phils; r 5 .83 and P , .001 for leukocytes), probably because
inflammatory cytokines and chemokines released in BM cause
neutrophil pleocytosis, metabolic changes, and cerebral hyp-
oxia [16–18].
The postoperative day on which the first lumbar puncture
was performed because of the clinical suspicion of BM was
significantly later (P , .001) for patients in the NBMS group
(10 6 7.6) than for patients in the BM group (5 6 2.2).
Subgroup analysis of the data showed no correlation between
the number of days after neurosurgery and the level of CSF
lactate in the BM and the NBMS groups and showed no
significant difference in CSF lactate level over time in patients
Figure 1. Concentration of lactate in CSF from patients with men-
ingeal syndrome after neurosurgery. CSF lactate values for patients
with proven bacterial meningitis (BM) (A) were significantly higher
than those for patients without BM (C) (mean 6 SD, 7.8 6 3.6 [n 5
12] vs. 2.3 6 0.8 mmol/L [n 5 47]; P , .0001), but they did not differ
markedly from those for patients with presumed BM (B) (6.7 6 3.3
[n 5 14]; P 5 NS vs. proven BM and P , .0001 vs. patients without
BM). A cutoff lactate concentration of 4 mmol/L (dotted line) differ-
entiated proven and presumed BM from nonbacterial meningitis with
a sensitivity of 88%, specificity of 98%, positive predictive value of
96%, and negative predictive value of 94%.












62/F Myelography 1 2 Escherichia coli
64/M Shunt
revision
4 1 Streptococcus oralis
44/M Intracerebral
hematoma
6 2 Klebsiella pneumoniae
72/F Vascular
malformation
2 1 Staphylococcus aureus
79/F Brain tumor 15 1 Peptostreptococcus magnus




6 1 Corynebacterium jeikeium







65/F Brain tumor 0 1 Coagulase-negative
Staphylococcus
28/M Brain tumor 9 1 Propionibacterium acnes
64/F Brain tumor 5 1 Propionibacterium acnes
NOTE. LP 5 lumbar puncture; 2 5 not present; 1 5 present.
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without BM, indicating that neurosurgery by itself did not
significantly alter CSF lactate level.
Discussion
The occurrence of bacterial meningitis after neurosurgery
has been documented in up to 4% of patients [24, 25]. The
diagnosis of BM relies on the isolation of bacteria from CSF
samples. However, in up to 70% of clinically suspected cases,
bacterial CSF cultures remain negative [3, 4]. In a recent study,
CSF samples were obtained from patients who had undergone
neurosurgery and had a meningeal syndrome and from clini-
cally negative controls. The samples were submitted to con-
ventional culture and to PCR with use of primers encoding for
a highly conserved region of eubacterial ribosomal DNA [26].
With this technique, the investigators obtained a positive
amplification result not only for CSF from patients whose
bacterial cultures of CSF were positive but also for CSF from
the majority of patients with clinical signs and laboratory
values suggestive of bacterial meningitis. In contrast, CSF from
control patients yielded no amplification products. The authors
concluded that many cases of culture-negative meningitis fol-
lowing neurosurgery are probably BM and that antibiotic treat-
ment is therefore justified.
The severe consequences of delayed or untreated BM, in
conjunction with the lack of clear diagnostic criteria for BM
occurring after neurosurgery, explain the prevailing practice of
empirically treating all suspected cases with high-dose broad-
spectrum intravenous antibiotics. The expense and risk of un-
necessary treatment of uninfected patients call for a more
specific test for the diagnosis of BM after neurosurgery.
Inflammation of the meninges in reaction to surgical proce-
dures is usually treated with high-dose steroids to prevent
adhesive arachnoiditis and hydrocephalus by their immunosup-
pressive action [4]. In cases of postoperative BM, however,
treatment with steroids and antibiotics further impairs the di-
agnostic value of CSF studies by decreasing inflammatory
parameters and the yield of bacterial cultures, respectively. In
this study, 45% of patients with a meningeal syndrome had
already been empirically treated with antibiotics, and 33% with
steroids, at the time of the first lumbar puncture.
The empirical use of antibiotics was equally high for patients
with BM and patients with NBMS, reflecting the difficulties in
distinguishing the diseases on clinical grounds. Steroids were
used more frequently in the group with later-confirmed BM
than in the group with NBMS. The higher proportion of steroid
treatment in the BM group might be explained by the fact that
symptoms of meningeal inflammation after neurosurgery are
frequently treated with steroids based on the assumption that
the condition is caused by NBMS. Only when symptoms
worsen or there is no clinical response to steroids, as in BM, is
a lumbar puncture performed to establish a diagnosis [4].
In 1917 Levinson [27] observed that spinal fluid from pa-
tients with meningococcal meningitis had a low pH. Killian
Table 2. Summary and predictive values of CSF lactate levels and








meningitis (n 5 12) 7.8 6 3.6 mmol/L 0.17 (0–1)
Presumed bacterial
meningitis (n 5 14) 6.7 6 3.3 mmol/L* 0.34 (0.1–0.9)†
Nonbacterial meningitis







NOTE. Cutoff values were 4 mmol/L for lactate level and 0.4 for
CSF/blood glucose ratio.
* P 5 NS vs. proven bacterial meningitis; P , .0001 vs. nonbacterial men-
ingitis syndrome.
† P 5 NS vs. proven bacterial meningitis; P , .0003 vs. nonbacterial
meningitis syndrome.
Figure 2. Ratio of CSF/blood glucose concentration for patients
with meningeal syndrome after neurosurgery. CSF/blood glucose
ratios for patients with proven bacterial meningitis (A) were signifi-
cantly lower than those for patients with nonbacterial meningitis (C)
(median [range], 0.17 [0–1] [n 5 12] vs. 0.54 [0.9–0.2] [n 5 47];
P , .0001) but did not differ markedly from those for patients with
presumed bacterial meningitis (B) (0.34 [0.1–0.9] [n 5 14]; P 5 NS).
A cutoff CSF/blood glucose ratio of 0.4 (dotted line) discriminated
between patients with culturally proven meningitis and patients with
nonbacterial meningitis but showed a considerable overlap of 30% in
the groups with presumed and nonbacterial meningitis. The
CSF/blood glucose ratio cutoff of 0.4 differentiated proven and pre-
sumed bacterial meningitis from nonbacterial meningitis with a sen-
sitivity of 77%, specificity of 87%, positive predictive value of 77%,
and negative predictive value of 87%.
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[28] recognized in 1925 that BM lowered the CSF glucose
concentration and elevated the CSF lactate level, and in 1933
De Sanctis et al. [29] reported that for the diagnosis of bacterial
meningitis, an increased CSF lactate level is more reliable than
a decreased CSF glucose level. Since then, many studies on
spontaneously occurring BM have confirmed and refined these
initial observations [6, 9–11, 22, 23]. However, the diagnostic
value of the CSF lactate level for patients after neurosurgery
has not been tested.
CSF lactate measurement has not found widespread accep-
tance as a discriminant CSF parameter for the diagnosis of
spontaneously occurring BM. Estimates of sensitivity and
specificity of the test vary, depending on the discriminant value
chosen. We chose 4.0 mmol/L as a cutoff CSF lactate value for
diagnosis of BM after neurosurgery. This value was slightly
modified from established discriminatory values for spontane-
ous meningitis [6, 9–11, 22, 23] in order to maximize the
diagnostic value for neurosurgical patients and to keep it sim-
ple enough to be remembered in clinical practice.
Inconsistencies in the reported diagnostic power of CSF
lactate measurement for spontaneous BM also depend upon the
patient populations in which the test has been applied. As for
any diagnostic procedure, the value of the test is diminished
when applied indiscriminately to CSF samples from patients in
whom BM is not suspected. In this study, the test was exclu-
sively applied to patients with clinically suspected BM.
The 34% prevalence of BM reflects the fact that this study
was performed in patients after neurosurgery in whom a bac-
terial cause of BM could not be ruled out on clinical grounds,
necessitating a diagnostic lumbar puncture. This prevalence is
comparable to that in two similar studies comparing culturally
proven BM with “aseptic” meningitis, in which BM occurred
after neurosurgery in 26%–42% of the patients [4, 26]. Thus,
the 34% prevalence of the disease in the tested population led
to a high predictive value.
Some authors have argued that despite its diagnostic value,
determination of the CSF lactate level does not offer more
information than standard CSF tests for the diagnosis of spon-
taneously occurring BM. For neurosurgical patients, however,
it has been shown that CSF studies (including gram staining
and determination of the total and differential leukocyte counts
and of glucose and total protein levels), neither alone nor in
combination, did not reliably distinguish BM from NBMS [4].
Therefore, determination of the CSF lactate level may contrib-
ute to the accurate diagnosis of BM in this population.
A positive correlation between the number of neutrophils
and the concentration of lactate in CSF has led some authors to
suggest that neutrophils are responsible for the rise in lactate
level in cases of BM and that the lactate level would therefore
not be more useful than the neutrophil count [30, 31]. In the
NBMS group, we found no significant correlation between the
CSF lactate concentration and the number of neutrophils or
leukocytes in CSF. However, in the BM group these parame-
ters were correlated, possibly as a reflection of the effect of
cytokines and chemokines released into the CSF, leading to
WBC invasion and a shift toward anaerobic metabolism by the
brain parenchymal cells.
Several lines of evidence argue against neutrophils as the
main source of CSF lactate. High concentrations of CSF lactate
have been found in patients with BM despite a low neutrophil
count [32]. This clinical observation has also been made in
experimental BM where high levels of CSF lactate were doc-
umented in neutropenic and normal control animals, indepen-
dent of the presence of neutrophils in CSF [21]. Moreover,
production of lactate during experimental BM has been local-
ized to brain tissue by in vivo microdialysis [33], and in vitro
experiments with neutrophils incubated in CSF showed very
low lactate production [32].
The high prevalence of a meningeal syndrome in neurosur-
gical patients underscores the need of a rapid and reliable test
to diagnose BM. Several properties of CSF lactate make de-
termination of such levels a valid ancillary test to use in
addition to standard biochemical and microbiological CSF
analysis. It is an inexpensive, easy, and rapidly performed
analysis that is already widely used for other clinical questions
in hospital-affiliated laboratories. As shown by other authors
and in this study, the CSF lactate level is not affected by the
presence of RBCs in the CSF [7, 8].
The slow clearance of lactate from CSF keeps high levels
elevated for up to 4 days, and determining these levels has been
particularly useful in identifying the significant proportion of
patients previously treated with antibiotics [34, 35]. In our own
clinical practice, determination of the CSF lactate level is now
routinely performed when postoperative meningitis is sus-
pected, and it provides useful additional information for the
difficult decision about whether to start empirical antibiotic
therapy.
In conclusion, the CSF lactate level (cutoff, 4 mmol/L) is
superior to the CSF/blood glucose ratio (cutoff, 0.4) for diag-
nosis of BM in neurosurgical patients (table 2). For patients
with a meningeal syndrome after neurosurgery, determination
of CSF lactate level is a quick, sensitive, and specific ancillary
test to identify the need for antimicrobial therapy.
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